XML 19 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
4 Months Ended 8 Months Ended 12 Months Ended
Dec. 31, 2017
Aug. 31, 2017
Dec. 31, 2016
Operating activities:      
Net (loss) income $ (13,327)    
Less: Income from discontinued operations, net of income taxes 0    
(Loss) income from continuing operations (13,327)    
Adjustments to reconcile loss from continuing operations to net cash used in operating activities of continuing operations:      
Depreciation and amortization 3,213    
Amortization of deferred financing costs and debt discount 1,958    
Debt restructuring loss, net 0    
Loss from lease termination 0    
Unrealized (gain) loss on embedded debt conversion option (2,352)    
Noncash interest paid in kind 3,865    
Noncash reorganization items, net 0    
Loss on sale of property, plant & equipment 26    
Unrealized gains on commodity hedges 0    
Unrealized foreign currency transaction (gain) loss (1,709)    
Equity in losses of joint venture 0    
Deferred income taxes (3,437)    
Non-cash compensation expense 866    
Other, net 634    
Changes in assets and liabilities:      
Accounts receivable (2,205)    
Inventories (1,978)    
Prepaid expenses and other current assets 752    
Other noncurrent assets 324    
Prepaid pension costs (1,395)    
Accounts payable (4,548)    
Accrued payroll and employee benefits 945    
Income tax payable and receivable (828)    
Accrued and other current liabilities (773)    
Postretirement benefit obligations and other noncurrent liabilities (585)    
Net cash used in operating activities of continuing operations (20,554)    
Net cash used in operating activities of discontinued operations 0    
Net cash used in operating activities (20,554)    
Investing activities:      
Proceeds from sale of investment in joint venture 0    
Capital expenditures (3,742)    
Proceeds from sale of property, plant and equipment 31    
Cash collateralization of letters of credit 0    
Net cash (used in) from investing activities of continuing operations (3,711)    
Net cash from investing activities of discontinued operations 0    
Net cash (used in) from investing activities (3,711)    
Financing activities:      
Short-term borrowings, net 1,720    
Proceeds from long-term debt including credit facilities 22,973    
Repayments of long-term debt including credit facilities (25)    
Payments of debt restructuring costs 0    
Payments of debt issue costs 0    
Payments of build-to-suit liability 0    
Net cash from (used in) financing activities 24,668    
Effect of exchange rate changes on cash and cash equivalents 637    
Net change in cash and cash equivalents 1,040    
Cash and cash equivalents—beginning of period 10,064    
Cash and cash equivalents—end of period 11,104 $ 10,064  
Predecessor      
Operating activities:      
Net (loss) income   36,190 $ (107,982)
Less: Income from discontinued operations, net of income taxes   0 6,108
(Loss) income from continuing operations   36,190 (114,090)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities of continuing operations:      
Depreciation and amortization   10,150 16,378
Amortization of deferred financing costs and debt discount   3,810 4,798
Debt restructuring loss, net   0 8,617
Loss from lease termination   0 2,200
Unrealized (gain) loss on embedded debt conversion option   146 (10,450)
Noncash interest paid in kind   0 0
Noncash reorganization items, net   (87,107) 0
Loss on sale of property, plant & equipment   7 1,874
Unrealized gains on commodity hedges   0 (1,015)
Unrealized foreign currency transaction (gain) loss   (4,439) 4,506
Equity in losses of joint venture   0 4,141
Deferred income taxes   (953) (4,354)
Non-cash compensation expense   630 1,154
Other, net   537 (80)
Changes in assets and liabilities:      
Accounts receivable   (6,061) 6,100
Inventories   (2,703) 65,712
Prepaid expenses and other current assets   (3,100) 1,358
Other noncurrent assets   1,664 1,993
Prepaid pension costs   (849) (59)
Accounts payable   8,602 (8,449)
Accrued payroll and employee benefits   (2,670) 300
Income tax payable and receivable   (340) (105)
Accrued and other current liabilities   (3,332) (6,514)
Postretirement benefit obligations and other noncurrent liabilities   (471) (3,063)
Net cash used in operating activities of continuing operations   (50,289) (29,048)
Net cash used in operating activities of discontinued operations   0 (5,914)
Net cash used in operating activities   (50,289) (34,962)
Investing activities:      
Proceeds from sale of investment in joint venture   0 31,550
Capital expenditures   (2,850) (3,499)
Proceeds from sale of property, plant and equipment   619 3,265
Cash collateralization of letters of credit   7,492 (7,968)
Net cash (used in) from investing activities of continuing operations   5,261 23,348
Net cash from investing activities of discontinued operations   0 53,570
Net cash (used in) from investing activities   5,261 76,918
Financing activities:      
Short-term borrowings, net   3,797 0
Proceeds from long-term debt including credit facilities   195,026 722,547
Repayments of long-term debt including credit facilities   (175,414) (725,821)
Payments of debt restructuring costs   0 (9,802)
Payments of debt issue costs   (1,831) (2,472)
Payments of build-to-suit liability   (3,000) (932)
Net cash from (used in) financing activities   18,578 (16,480)
Effect of exchange rate changes on cash and cash equivalents   890 (952)
Net change in cash and cash equivalents   (25,560) 24,524
Cash and cash equivalents—beginning of period $ 10,064 35,624 11,100
Cash and cash equivalents—end of period   $ 10,064 $ 35,624